Temple Run: Eternal CEO Deepinder Goyal In Face-Off With Doctors Over Wearable Device
Temple, the wearable device startup founded by former Eternal CEO Deepinder Goyal, has come under scrutiny from doctors over its scientific claims, prompting the entrepreneur to publicly defend the product and reject allegations that it is misleading consumers. In a series of posts on social media platform X, Goyal said Temple's claims would be quickly tested by users once the device reaches…
Deepinder Goyal, the former CEO of Eternal, is embroiled in a dispute with doctors over wearable device startup Temple's scientific assertions. The controversy has led Goyal to address the concerns directly on social media platform X, vowing to prove the device's claims through user testing and eventual clinical validation.
Goyal dismissed accusations that Temple is misleading consumers, emphasizing that the company offers a 14-day no-questions-asked return policy and is not a medical device. He clarified that Temple is a fitness tracker and wellness device, and scientific validation, if achieved, would be communicated to consumers promptly.
Investing approximately $30 million in Temple's development, Goyal, including around $20 million of his own capital, defended the substantial financial commitment as evidence of the company's credibility. He acknowledged that Temple has not yet clinically validated all of its metrics but assured that the validation process would be transparent.
Temple's CEO addressed specific criticisms from hepatologist Cyriac Abby Philips, popularly known as The Liver Doc, who questioned the device's ability to assess brain-related metrics. Philips alleged insufficient evidence supporting Temple's claims regarding brain blood flow and other advanced metrics, questioning the company's assertions of scientific accuracy.
Goyal countered by asserting Temple's commitment to scientific validation and independent studies, while critics demanded independent peer-reviewed evidence before accepting the device's health-related claims.
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
